Physician

Alan Koff

According to 2025 Medicare claims, Alan Koff (NPI: 1407239700) practices infectious disease in the Sacramento-Roseville-Folsom, CA market, with the plurality of this provider's patient population coming from Sacramento, CA. This provider's primary affiliated billing organization is REGENTS OF THE UNIV OF CA (NPI: 1437142452; TIN: 680334324) and primary practice location at 95817-2201.

Koff's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 145 traditional Medicare patients, billed 491 HCPCS/CPT codes, and received $34,856 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 161 prescription claims across 30 beneficiaries totaling $375,433 in drug costs, led by Biktarvy (Bictegrav/Emtricit/Tenofov Ala). Open Payments data shows 1 records totaling $63,681. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $191 to $375,433. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$25K$51K2020 Medicare payment: $21,179 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $50,595 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $36,511 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $31,158 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $34,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202097242$21,179
2021204589$50,595
2022162446$36,511
2023151365$31,158
2024145491$34,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$377K$754K2015 Drug cost: $191 (USD; Tot_Drug_Cst)2016 Drug cost: $1,402 (USD; Tot_Drug_Cst)2017 Drug cost: $2,865 (USD; Tot_Drug_Cst)2020 Drug cost: $154,373 (USD; Tot_Drug_Cst)2021 Drug cost: $321,745 (USD; Tot_Drug_Cst)2022 Drug cost: $753,619 (USD; Tot_Drug_Cst)2023 Drug cost: $425,949 (USD; Tot_Drug_Cst)2024 Drug cost: $375,433 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R14$191
20161735$1,402
20174986$2,865
2018N/RN/RN/R
2019N/RN/RN/R
20202682$154,373
202161248$321,745
202252271$753,619
202337191$425,949
202430161$375,433

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2929$140
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes3233$105
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more3646$77
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes59162$63
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4162$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BiktarvyBictegrav/Emtricit/Tenofov Ala33990$132,143
JulucaDolutegravir/Rilpivirine18840$95,888
FluconazoleFluconazole11720$456
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim13690$313
CephalexinCephalexin12720$138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.0$0N/R
Research PaymentsReported research-related payment or transfer-of-value amount.1$63,681AstraZeneca UK Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alan Koff?

Tedicare shows public-source Medicare data for Alan Koff (NPI 1407239700), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alan Koff have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alan Koff?

Alan Koff is linked to REGENTS OF THE UNIV OF CA (billing NPI 1437142452) in the available physician profile data.

Does Alan Koff have Open Payments data?

Alan Koff has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.